Sign Up to like & get recommendations! 0
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.24750
Abstract: Key Points Question What are the epidemiologic trends of and prognostic factors for gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in patients in the US? Findings In this cohort study of 43 751 patients with GEP-NETs, most cases occurred… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "JAMA Oncology"
DOI: 10.1001/jamaoncol.2018.2428
Abstract: There is no consensus on optimal follow-up for completely resected gastroenteropancreatic neuroendocrine tumors. Published guidelines for follow-up are complex and emphasize closer surveillance in the first 3 years after resection. Neuroendocrine tumors have a different… read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2232
Abstract: Although the postoperative recurrence rate for pancreatic neuroendocrine tumors (PNETs) is reported to be 13.5%‐30%, the paucity of valuable biomarkers to predict recurrence poses a problem for the early detection of relapse. Hence, this study… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Cancer"
DOI: 10.1002/cncr.32865
Abstract: The Chicago Consensus Working Group provides multidisciplinary recommendations for the management of neuroendocrine tumors specifically related to the management of peritoneal surface malignancy. These guidelines are developed with input from leading experts, including surgical oncologists,… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.23635
Abstract: Mitotic count in hematoxylin‐eosin stained slides and Ki‐67 index allow stratification of patients for prognosis and therapeutic decision making in pancreatic neuroendocrine tumors (PNETs). However, the utility of Ki‐67 determination in cytological material and its… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24088
Abstract: Homeobox transcription factors have demonstrated utility in diagnosing neuroendocrine tumors. Orthopedia homeobox protein (OTP) has a well‐defined role in embryonic neurodevelopment and has also been described as a prognostic marker in lung neuroendocrine tumors (NET).… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24640
Abstract: Adenomatous neuroendocrine tumors of the middle ear (MEANTs) are very rare neoplasms which are composed of both epithelial and neuroendocrine components. They have mostly bland histology and indolent biological behavior, yet they may recur and… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "International Journal of Cancer"
DOI: 10.1002/ijc.31589
Abstract: We investigated whether obesity and sociodemographic factors at adolescence are associated with incident gastroenteropancreatic neuroendocrine tumors (GEP‐NET).Our cohort included 2.3 million Israeli adolescents examined at ages 16 to 19 years between 1967 and 2010. The baseline… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Journal of hepato-biliary-pancreatic sciences"
DOI: 10.1002/jhbp.1101
Abstract: BACKGROUND The present prospective phase 1/2 study aimed to elucidate the efficacy and safety of 177 Lu-DOTATATE (four cycles of 7.4 GBq) in Japanese patients with unresectable, progressive neuroendocrine tumors (NETs). METHODS From April 2018… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25689
Abstract: The benefit derived from lymph node dissection (LND) in patients with pancreatic neuroendocrine tumors (pNETs) based on clinicopathological characteristics remains unclear. read more here.
Sign Up to like & get recommendations! 1
Published in 2019 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.25727
Abstract: Ileal neuroendocrine tumors (i‐NETs) frequently metastasize to mesenteric lymph nodes and the liver. Regional lymphadenopathy is associated with desmoplasia of the mesentery forming a large mesenteric mass (LMM). Although the latest American Joint Committee on… read more here.